Medicated Pain Relief Patches

Description

This product is distributed by C.D.M.A., Inc., located at 43157 W. Nine Mile, Novi, MI 48375. It is manufactured in China and is available in a box containing 60 units. The product should be stored in a clean, dry place, away from direct sunlight, and protected from excessive moisture.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects.

• Concurrent use with a heating pad is contraindicated as it may enhance absorption and increase the risk of systemic effects.

• Patients with known allergies to any ingredients in this product should not use it to prevent allergic reactions.

• Contact with eyes, mucous membranes, or rashes must be avoided to prevent irritation and potential complications.

• Tight bandaging of the application site is not recommended, as it may lead to increased local irritation.

• Simultaneous use with other topical analgesics is contraindicated to avoid potential additive effects and increased risk of adverse reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a known allergy to aspirin or salicylates, as this product may provoke an allergic reaction in susceptible individuals.

It is imperative to exercise caution when using this product. It should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad. Additionally, patients must be informed not to use the product if they are allergic to any of its ingredients.

Patients should be instructed to discontinue use and seek medical attention if they experience any of the following: rash, itching, or excessive skin irritation. Furthermore, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, patients should contact their healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware of the potential for adverse reactions associated with the use of this medication.

In terms of serious reactions, individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use. This precaution is particularly important for those who have a history of allergic reactions, as it may pose significant health risks.

Common adverse reactions may include skin-related issues. Patients are advised to discontinue use and seek medical attention if they experience rash, itching, or excessive skin irritation. Additionally, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days, it is recommended that patients consult a healthcare provider for further evaluation and guidance.

These recommendations are based on clinical observations and are intended to ensure patient safety during the use of this medication.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimize treatment efficacy. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a need to transition between topical analgesics.

Packaging & NDC

Below are the non-prescription pack sizes of Medicated Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

It is advisable to monitor elderly patients closely for any potential adverse effects or changes in therapeutic response, given the lack of detailed guidance on geriatric use. Individualized assessment and clinical judgment are recommended to ensure the safe and effective use of this medication in the elderly population.

Pregnancy

Safety during pregnancy has not been established for this medication. It is not recommended for use during pregnancy due to potential risks associated with the active ingredients, which may pose risks to the developing fetus. Pregnant patients are advised to consult a healthcare provider prior to use to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there is no information provided regarding the potential for excretion in breast milk or any associated risk to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the context of overdosage, there is currently no specific information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse reactions that may arise.

In the absence of detailed overdosage data, it is recommended that standard supportive measures be employed. This includes ensuring the patient's safety, providing symptomatic treatment, and considering the use of activated charcoal if the overdose is recent and the patient is alert.

Healthcare providers should remain vigilant and report any observed adverse effects to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they have a known allergy to any of its ingredients. They should be counseled to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be advised to stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Healthcare providers should emphasize the importance of using the product only as directed and to avoid contact with eyes, mucous membranes, or rashes. Patients should be instructed not to bandage the area tightly and to refrain from using the product simultaneously with other topical analgesics.

Finally, it is crucial to inform patients about the safe disposal of used patches, ensuring they are kept out of reach of children and pets, as used patches still contain the drug product that can lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and efficacy.

Healthcare professionals are advised to dispose of used patches responsibly. It is crucial to keep used patches out of reach of children and pets, as they may still contain active drug components that could lead to serious adverse effects if ingested or chewed.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is advised prior to use.

Clinicians should counsel patients on several important safety measures. Patients with a history of allergic reactions to aspirin or salicylates should consult a doctor before use. Used patches must be disposed of properly to prevent accidental ingestion by children or pets, as they still contain active drug that can lead to serious adverse effects. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if ingested.

Drug Information (PDF)

This file contains official product information for Medicated Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)